Results 81 to 90 of about 77,493 (312)

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development

open access: yesEpilepsia, EarlyView.
Abstract Over the last 34 years, the Eilat Conference on New Antiepileptic Drugs and Devices has provided an interactive forum for stakeholders to discuss investigational and recently licensed treatments for seizures and epilepsy. The Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII) took place in Madrid, Spain, on May 3 ...
Meir Bialer   +7 more
wiley   +1 more source

Factores asociados a alopecia no cicatricial en mujeres adultas, estudio transversal entre enero y diciembre 2013 [PDF]

open access: yes, 2018
Introducción. Alopecia significa caída patológica del pelo, de cualquier tipo y en cualquier lugar de la superficie cutánea. Se divide en dos grandes grupos: cicatricial y no cicatricial.
Uribe-Caputi, Juan Carlos   +2 more
core   +2 more sources

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey

open access: yesInternational Journal of Women's Dermatology, 2023
Ogechi Ezemma, BA   +6 more
doaj   +1 more source

Folliculotropic mycosis fungoides: clinical and histologic features in five patients

open access: yesIndian Journal of Dermatology, 2016
Background: Alopecia can be a manifestation of mycosis fungoides (MF); however, the prevalence is unknown. Aims: We sought to describe the clinicopathologic presentation of alopecia in patients with diagnosis of MF.
Amir Hooshang Ehsani   +7 more
doaj   +1 more source

Severe plaque psoriasis with coexisting cicatricial alopecia treated with adalimumab – case report [PDF]

open access: yes, 2014
Introduction. Tumor necrosis factor α (TNF-α) inhibitors are used in the management of many immune-mediated diseases, including the treatment of severe plaque psoriasis. Lichen planopilaris is an inflammatory dermatosis, which typically affects women at
Aldona Pietrzak   +3 more
core   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

CORTICOSTEROID AS TREATMENT OF ALOPECIA AREATA

open access: yese-Jurnal Medika Udayana, 2013
Alopecia areata is a common cause of alopecia nonscarring. Incidence alopecia areata 1-2% of the population, with the same ratio in both sexes, and occurs in all racial groups.
Ni Putu Junika Putri, I Wayan Sugiritama
doaj  

Skin ageing [PDF]

open access: yes, 2007
Cutaneous ageing manifests itself as a progressive reduction in maximum function and reserve capacity of skin tissue. It is not a unique and uniform biological event. Skin comprises three layers: epidermis, dermis and subcutaneous tissue.
Brincat, Mark P.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy